Cargando...
An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers
BACKGROUND: CD3-based bispecific T cell engagers (bsTCEs) are one of the most promising bispecific antibodies for effective cancer treatments. To elicit target-specific T cell-mediated cytotoxicity, these bsTCEs contain at least one binding unit directed against a tumor antigen and another binding u...
Gardado en:
| Publicado en: | Antib Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220303/ https://ncbi.nlm.nih.gov/pubmed/34169228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tbab009 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|